BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to specialty and orphan oncology products, today announced that it has won first prize in “Deloitte’s Technology Fast 50” 2011 ranking of fastest-growth technologies companies, as well first prices “Biotech and Health sector” and “Nyse Euronext” in national Fast 50 ranking. BioAlliance Pharma also received first prize in regional “Ile-de- France Fast 50” ranking.
This ranking is drawn up according to turnover growth over the fiscal years 2006 to 2010. During this period, BioAlliance Pharma’s earnings substantially grew (4 800%) to reach €22.5 million in 2010. This strong increase is due to the steps successfully achieved on Loramyc® by the Company over the last years: development, registration, price negotiation and partnership on an international level.
“BioAlliance Pharma’s team is proud of these awards, symbolizing our know-how and expertise. We belong to the very few small- and medium-sized innovative companies in this area which have achieved all these steps. The domain of drug development is a path paved with difficulties where excellence, engagement and a dose of luck are the keys of success”, declares Judith Greciet, CEO of BioAlliance Pharma. “Through all these years, we have pursued a growth strategy based on a balanced product portfolio in terms of progress phases as well as market potential. It is the second time BioAlliance ranks first in the “Deloitte Technology Fast 50”; it represents a strong signal of our ability to create long-term value. This would have not been possible without our financial and industrial partners’ confidence and support all along the way”.
“Inclusion in the first technologies companies with strong growth is an impressive exploit. We heartily congratulate BioAlliance Pharma on being on Technology Fast 50 program at Deloitte and for its outstanding growth rate over 5 years”, declares Ariane Bucaille, partner in charge of the Technology Fast 50 at Deloitte.
About the Deloitte Technology Fast 50
The Deloitte Technology Fast 50 was established in San Jose, California, in 1995. The growing programme now spans the globe and supplements the broader Deloitte Technology Fast 500 initiative as the local winners are automatically entered into the Fast 500 programme.
The Technology Fast 500 EMEA pre-eminent technology awards programme is a ranking of Europe, the Middle East and Africa’s fastest-growing technology companies based on percentage revenue growth over five years. To learn more about a Deloitte Technology Fast 50 programme in France, please visit our website: www.fast50france.com
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. In France, Deloitte SA is the member firm of Deloitte Touche Tohmatsu Limited, and professional services are provided by its subsidiaries and affiliates.
Deloitte provides audit, tax, consulting, and financial advisory services to public and private clients spanning multiple industries. With a globally connected network of member firms in more than 150 countries, Deloitte brings world-class capabilities and deep local expertise to help clients succeed wherever they operate. Deloitte’s approximately 182,000 professionals are committed to becoming the standard of excellence.
In France, Deloitte calls on diversified expertise to meet the challenges of its clients of all sizes from all industries – major multinationals, local micro-companies and medium-sized enterprises. With the expertise of its 6,500 professionals and partners, Deloitte is a leading player in audit and risk services, consulting, financial advisory services, tax & legal and accounting, based on a multidisciplinary offering and a set of action principles attuned to the requirements of our environment.